<p>Pfizer Inc said on Tuesday that along with partner BioNTech Se it was developing a booster shot to protect against Covid-19 variants.</p>.<p>"We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to <em>Reuters</em>.</p>.<p>However, the company added that studies needed to evaluate the booster shot are yet to be determined in agreement with regulators.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-vaccine-live-news-updates-astrazeneca-oxford-bharat-biotech-covaxin-covishield-healthworkers-free-vaccine-vaccination-drive-india-serum-institute-narendra-modi-943780.html"><strong>Follow live updates on the coronavirus vaccine on DH</strong></a></p>.<p>The story was first reported by <em>Bloomberg News</em>.</p>.<p>Moderna Inc, whose vaccine has also been authorized for emergency use in the United States, had said on Monday it would test a new booster shot aimed at the South African variant of the coronavirus after concluding the antibody response could be diminished.</p>
<p>Pfizer Inc said on Tuesday that along with partner BioNTech Se it was developing a booster shot to protect against Covid-19 variants.</p>.<p>"We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to <em>Reuters</em>.</p>.<p>However, the company added that studies needed to evaluate the booster shot are yet to be determined in agreement with regulators.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-vaccine-live-news-updates-astrazeneca-oxford-bharat-biotech-covaxin-covishield-healthworkers-free-vaccine-vaccination-drive-india-serum-institute-narendra-modi-943780.html"><strong>Follow live updates on the coronavirus vaccine on DH</strong></a></p>.<p>The story was first reported by <em>Bloomberg News</em>.</p>.<p>Moderna Inc, whose vaccine has also been authorized for emergency use in the United States, had said on Monday it would test a new booster shot aimed at the South African variant of the coronavirus after concluding the antibody response could be diminished.</p>